推荐产品
包裝
pkg of 1 × 25 mL
濃度
(TMSI+Pyridine, 1:4)
SMILES 字串
c1ccncc1.C[Si](C)(C)n2ccnc2
InChI
1S/C6H12N2Si.C5H5N/c1-9(2,3)8-5-4-7-6-8;1-2-4-6-5-3-1/h4-6H,1-3H3;1-5H
InChI 密鑰
PFVKFOIOKNIZKY-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
應用
TMSI+PYRIDINE, 1:4 (Sylon™ TP) may be used as a derivatization reagent for the measurement of liver and plasma precursor sterols using gas chromatography coupled with mass spectrometry while investigating the dual-action glycogenolysis/cholesterolgenesis inhibitors that act through inhibition of both glycogen phosphorylase and CYP51.
法律資訊
Sylon is a trademark of Sigma-Aldrich Co. LLC
訊號詞
Danger
危險分類
Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
3 - Flammable liquids
水污染物質分類(WGK)
WGK 3
閃點(°F)
62.6 °F - closed cup
閃點(°C)
17 °C - closed cup
Comparison between Solvent Extraction Using Gas Chromatography Mass Spectrometry Triple Quadrupole (GCMS-QQQ) of Cholesterol and Cholesterol Oxidation Derivatives
Middle-East Journal of Scientific Research 13, 13, 43-48 (2013)
Journal of lipid research, 46(3), 547-563 (2004-12-18)
Diabetic dyslipidemia requires simultaneous treatment with hypoglycemic agents and lipid-modulating drugs. We recently described glycogen phosphorylase inhibitors that reduce glycogenolysis in cells and lower plasma glucose in ob/ob mice (J. Med. Chem., 41: 2934, 1998). In evaluating the series prototype
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门